key: cord-0772993-3a99czmc authors: Ohnishi, Masato; Tanaka, Yasunori; Nishida, Sakiya; Sugimoto, Toshiro title: Case report of acute myocarditis after administration of COVID-19 vaccine in Japan date: 2022-01-05 journal: Eur Heart J Case Rep DOI: 10.1093/ehjcr/ytab534 sha: 45a4a15512a9ca68b04392f033f51cb72f557cc9 doc_id: 772993 cord_uid: 3a99czmc BACKGROUND: The worldwide spread of Coronavirus disease 2019 (COVID-19) is still not under control and vaccination in Japan started in February 2021, albeit later than in Europe and the United States of America. The COVID-19 vaccination frequently leads to minor adverse reactions, that may be more intense after the second dose. The number of case reports of myocarditis following COVID-19 vaccination have been recently increased. CASE SUMMARY: We report a case of a 26-year-old healthy man who presented to our hospital with chest pain on May 24 2021, 4 days after his second COVID-19 vaccination. The electrocardiogram showed ST elevation with upward concavity in I, II, aVL, aVF, V4 to V6, and small Q wave in II, III, aVF. Laboratory studies revealed elevation of troponin-I, creatine kinase, C-reactive protein and negative viral serologies. Acute aortic dissection and pulmonary thromboembolism were ruled out by contrast-enhanced thoracoabdominal computed tomography (CT). An urgent coronary angiogram was performed because an acute coronary syndrome was suspected, but no significant stenosis was found. Cardiac magnetic resonance imaging (MRI) demonstrated oedema and late gadolinium enhancement of the left ventricle in a midmyocardial and epicardial distribution. DISCUSSION: Although the temporal association does not prove causation, the very short span between the second vaccination and the onset of myocarditis suggests that this acute myocarditis seemed to be an adverse reaction to COVID-19 vaccine. To the best of our knowledge, this is the first published case of acute myocarditis following COVID-19 vaccine in Asia. Learning points: 12 ・As Coronavirus disease 2019 (COVID-19) vaccination has increased, reports of adverse 13 reactions have also increased. 14 ・We should be aware that acute myocarditis after administration of COVID-19 vaccine 15 may also occur even in healthy young men without immune abnormalities. 16 ・Cardiac magnetic resonance imaging is useful in the diagnosis of acute myocarditis. Event . 30 April First dose of COVID-19 vaccine. which was treated with acetaminophen. 23 May Onset of chest pain and persistent fever, headache, appetite loss. The patient visited outpatient clinic and was admitted to the high care unit (HCU); elevated markers of myocardial damage such as highsensitivity troponin I, Creatine Kinase, C-reactive protein, diffuse STsegment elevation on electrocardiogram (ECG). An urgent coronary angiogram showed no significant stenosis. anti-inflammatory drugs were started and the patient's symptoms improved. The patient was haemodynamically stable and asymptomatic. A subsequent ECG showed partial resolution of the ST changes and a trend towards improvement. The patient was discharged in order to perform cardiac magnetic resonance imaging (MRI). The patient visited outpatient clinic with mild general fatigue. Cardiac MRI showed myocardial late gadolinium enhancement with epicardial predominance in the antero-septal, inferior and lateral walls of the basal segment and apex, which were consistent with acute myocarditis. The patient recovered and returned to work. 14 June Despite no deterioration in cardiac function, the patient complained of appetite loss and fatigue on exertion, was diagnosed as post-vaccination syndrome and was absent from work for a month. The patient recovered to some extent and returned to work. The patient complained of general malaise and sleep disturbance, was diagnosed as depressive state and is currently on leave. there are no published case reports of COVID-19 vaccine related myocarditis in Asia. (Table) . Cardiac magnetic 6 resonance imaging (MRI) examination, which was obtained on discharge 6 days after especially those in their twenties, is still largely unavailable. Therefore, as vaccination 9 spreads to the younger generation, there is a concern that cases of myocarditis and 10 pericarditis may increase. The Ministry of Health, Labour and Welfare announced 12 11 cases of Myocarditis/pericarditis as of 2 July, and the Japanese Circulation Society issued 12 a statement on "Acute myocarditis and acute pericarditis after vaccination with novel 13 coronaviruses" on 21 July. We healthcare providers have to pay attention to this issue as 14 vaccination in Japan will progress from the elderly to the younger generation. However, 15 it appears that there is a significantly higher risk of cardiac involvement from COVID-19 16 infection compared to . We therefore believe that COVID-19 17 vaccination plays an important role in herd immunity and overall provide more benefit than harm. 1 The patient was a medical professional and was well aware that myocarditis can be fatal 2 in severe cases, which may have been traumatic and led to depressive state. It is a priority 3 to provide psychological support for the post-traumatic stress disorder (PTSD)-like 4 depression which can occur as an adverse complication of the vaccine. In conclusion, to the best of our knowledge, this is the first published case of acute 6 myocarditis as an adverse reaction to SARS-CoV-2 vaccine in Asia. Center for Disease Control and Prevention. Possible Side Effects After Getting a 14 COVID-19 Vaccine Markers of myocardial injury and inflammatory response have improved within one week HS-Tn-I, high-sensitivity troponin-I WBC, white blood cell We thank Dr Hiroshi Sakai (Department of Cardiology, Shiga University of Medical Sciences, Otsu, Japan) for arranging the cardiac MRI and Dr Yukihiro Nagatani (Department of Radiology, Shiga University of Medical Sciences, Otsu, Japan) for reading the cardiac MRI.